Clinical Trials Directory

Trials / Completed

CompletedNCT02198950

Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis

Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis: a Prospective, Bicentric Study

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine wether the combined measurement of the soluble form of TREM-1, PCT and the determination of neutrophils CD64 expression could diagnose sepsis in critically ill patients.

Conditions

Timeline

Start date
2009-11-01
Primary completion
2011-10-01
Completion
2011-12-01
First posted
2014-07-24
Last updated
2020-09-18

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02198950. Inclusion in this directory is not an endorsement.

Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis (NCT02198950) · Clinical Trials Directory